Deston Injection 8mg/4ml – Intravenous & Intramuscular Antihistamine Therapy

Product Overview

Deston Injection 8mg/4ml is a high-potency parenteral second-generation antihistamine formulation containing Desloratadine / Active Antihistaminic Agent (8mg per 4ml ampoule). Engineered for immediate systemic bioavailability via Intravenous (IV) or Intramuscular (IM) administration, Deston Injection is indicated for the acute management of severe allergic reactions, acute urticaria, angioedema, allergic conjunctivitis, and as an adjunctive treatment in emergency anti-anaphylactic protocols. By bypassing gastrointestinal absorption, it delivers rapid systemic inhibition of histamine pathways during acute clinical emergencies.

Key Benefits

• Rapid Onset of Action: Immediate systemic absorption provides fast relief during acute allergic emergencies and severe flare-ups.

• Controls Severe Urticaria & Angioedema: Rapidly suppresses intense cutaneous itching, wheals, localized edema, and skin swelling.

• Upper Respiratory & Mucosal Relief: Swiftly halts severe allergic rhinitis, profuse rhinorrhea, mucosal congestion, and ocular allergic symptoms.

• Emergency Clinical Utility: Serves as a key adjunctive therapy alongside primary agents (such as epinephrine and corticosteroids) in systemic allergic protocols.

• Flexible Parenteral Administration: Formulated for slow Intravenous (IV) injection/infusion or deep Intramuscular (IM) administration.

How It Works

Deston Injection 8mg/4ml acts as a potent, highly selective peripheral histamine H1​-receptor antagonist. During acute allergen exposure, systemic mast cells and basophils rapidly degranulate, releasing large amounts of histamine into circulation. Histamine binding to H1​ receptors causes capillary hyperpermeability, smooth muscle contraction, vasodilation, and nerve irritation. Deston competitively blocks these peripheral H1​ receptors, halting the inflammatory response cascade at the vascular and tissue level.

Key Active Ingredients

• Active Antihistaminic Agent (8mg per 4ml ampoule): Parenteral second-generation H1​-receptor antagonist engineered for rapid neutralization of systemic histamine activity.

Directions for Use

1. Administration: For slow Intravenous (IV) injection, IV infusion, or deep Intramuscular (IM) injection only.

2. Clinical Dosing:

   • Acute Allergic Episodes: Typically 4ml (8mg) administered slowly, or as directed by the attending emergency physician based on patient age, weight, and severity.

   • Infusion: May be diluted in compatible parenteral infusion fluids (such as 0.9% Sodium Chloride) for controlled IV delivery.

3. Professional Healthcare Use: Must be administered exclusively by a qualified healthcare professional in a hospital, clinic, or emergency care environment.

Precautions

• Prescription-Only Parenteral: Strictly for professional healthcare administration; do not self-administer.

• Exercise caution and adjust dosage in patients with severe renal or hepatic impairment.

• Monitor clinical vital signs when administering alongside epinephrine or steroids during severe anaphylactic reactions.

• May cause mild transient sedation or dizziness in sensitive individuals; advise patients to avoid driving or operating heavy machinery immediately post-administration.

• Consult an attending physician before use during pregnancy or lactation.

• Keep out of reach of children.

Storage Instructions

Store in a cool, dry place below 30°C. Protect from direct light, heat, and freezing. Use immediately once the ampoule is opened; discard any unused solution.

Manufacturer Information

Formulated and manufactured in strict compliance with international pharmaceutical quality standards, dedicated to developing high-potency parenteral therapies for critical allergic care, respiratory health, and emergency medicine.